Drugmaker Pfizer Inc said on Tuesday no country in the developed world will get a lower price for its experimental COVID19 vaccine than the United States if those countries make similar volume commitments.
Drugmaker Pfizer Inc said on Tuesday no country in the developed world will get a lower price for its experimental COVID-19 vaccine than the United States if those countries make similar volume commitments.
The U.S. government said last week it will pay nearly $2 billion to buy enough of the COVID-19 vaccine being developed by Pfizer Inc and German biotech BioNTech SE to inoculate 50 million people if it proves to be safe and effective. That amounts to a $39 price tag.
Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor
Comments
0 comment